Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. May 27, 2025; 17(5): 101605
Published online May 27, 2025. doi: 10.4240/wjgs.v17.i5.101605
Table 6 Comparative analysis of safety assessment between the two groups, n (%)

Experimental group (n = 45)
Control group (n = 44)
χ2
P value
Adverse reaction5 (11.11)13 (29.55)4.6860.030
Decreased appetite1 (2.22)2 (4.55)
Diarrhea1 (2.22)1 (2.27)
Headache0 (0.00)1 (2.27)
Lethargy1 (2.22)3 (6.82)
Liver function damage0 (0.00)1 (2.27)
Rash1 (2.22)1 (2.27)
Abnormal blood pressure0 (0.00)1 (2.27)
Heart function abnormalities0 (0.00)1 (2.27)
Reactive telangiectasia1 (2.22)2 (4.55)